Heron Therapeutics Inc

NASDAQ: HRTX
Share price (5/17/24): $3.20
Market cap (5/17/24): $482 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

8 Heron Therapeutics Inc Expert Interviews, now on BamSEC.

Powered by Tegus.

Financials Filter

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

ended 06/30/23 Q2

ended 03/31/23 Q1

Prospectuses and Registrations Filter

Prospectus supplement

Shelf registration

Exempt offering of securities

Registration of securities for employees

Prospectus supplement for primary offering

Ownership Filter

Forbes William P

Collard Craig A

Collard Craig A

Great Point Partners LLC

News Filter

Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates

Change in Directors, Officers or Compensation

Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates

Announces FDA Approval of ZYNRELEF® Indication Expansion to Include Additional Orthopedic and Soft Tissue Procedures

Announces Partnership With CrossLink Life Sciences to Expand Promotional Effort for ZYNRELEF®, the First and Only Non-Opioid Dual Acting Local Anesthetic for Post-Operative Pain

Proxies Filter

Definitive proxy

Preliminary proxy

Definitive proxy

Preliminary proxy

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission